MangoceuticalsMGRX

13F holders, Q3 2024 (September 30)
1holders
$0.24avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings. The largest holder was Captrust Financial Advisors ($4K).

Company
Mangoceuticals Inc.
CUSIP
56270V205
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2024: 1Q3 2024Q4 2024: 9Q4 2024Q1 2025: 8Q1 2025Q2 2025: 10Q2 2025Q3 2025: 11Q3 2025Q4 2025: 18Q4 2025Q1 2026: 18Q1 2026Q2 2026: 18Q2 2026

Total Exit/New Position Q3 2024

InstitutionsTotal Value
New Positions1$4K
Exits0$0

Ownership 1 holders

Captrust Financial Advisors 0.00% New 17,077 $4K

"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.